| Date | Form | Description | Docs | XBRL | Pages |
| 03/10/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 01/21/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/16/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/15/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/14/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/10/20 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
110 | |
| 01/09/20 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...